Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022
Archives of Virology · 2024
DOI: 10.1007/s00705-024-06016-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, 2024. Verfasst von Ayako Sedohara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. sedohara@ims…. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Education, Culture, Sports, Science, and Technology of Japan., The University of Tokyo.
Abstract (Originalsprache)
Missense mutations in certain small envelope proteins diminish the efficacy of antibodies. Consequently, tracking the incidence and types of vaccine-escape mutations (VEMs) was crucial both before and after the introduction of universal hepatitis B vaccination in Japan in 2016. In this study, we isolated hepatitis B virus (HBV) DNA from 58 of 169 hepatitis B surface antigen (HBsAg)-positive blood samples from Japanese blood donors and determined the nucleotide sequence encoding the small envelope protein. DNA from six (10%) of the samples had VEMs, but no missense mutations, such as G145R, were detected. Complete HBV genome sequences were obtained from 29 of the 58 samples; the viral genotype was A1 in one (3%), A2 in three (10%), B1 in nine (31%), B2 in five (17%), B4 in one (3%), and C2 in 10 (34%) samples. Tenofovir-resistance mutations were detected in two (7%) samples. In addition, several core promoter mutations, such as 1762A>T and 1764G>A, and a precore nonsense mutation, 1986G>A, which are risk factors for HBV-related chronic liver disease, were detected. These findings provide a baseline for future research and highlight the importance of ongoing monitoring of VEMs and drug resistance mutations in HBV DNA from HBsAg-positive blood donors without HBV antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. sedohara@ims.u-tokyo.ac.jp.
- Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
- Department of Infectious Disease and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
- Department of Infectious Diseases, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Förderung
- the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
- The University of Tokyo
Zitieren
APA
Sedohara, A., Takahashi, K., Arai, K., Arizono, K., Tuvshinjargal, K., Saito, M., Nakahara, F., Tsutsumi, T., Ikeuchi, K., Adachi, E., & Yotsuyanagi, H. (2024). Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022. Archives of Virology. https://doi.org/10.1007/s00705-024-06016-4
Vancouver
Sedohara A, Takahashi K, Arai K, Arizono K, Tuvshinjargal K, Saito M, et al. Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022. Archives of Virology. 2024. doi:10.1007/s00705-024-06016-4
BibTeX
@article{Sedohara2024,
author = {Sedohara, Ayako and Takahashi, Kazuaki and Arai, Keiko and Arizono, Kotaro and Tuvshinjargal, Khulan and Saito, Makoto and Nakahara, Fumio and Tsutsumi, Takeya and Ikeuchi, Kazuhiko and Adachi, Eisuke and Yotsuyanagi, Hiroshi},
title = {Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022},
journal = {Archives of Virology},
year = {2024},
doi = {10.1007/s00705-024-06016-4}
}
EUVIMED